EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Candesartan restores blood–brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis

Michael F Hammer iD, Erfan Bahramnejad, Joseph C Watkins, Patrick T Ronaldson

Clinical Science · 2024

DOI: 10.1042/cs20240771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Michael F Hammer und 3 weiteren Autor:innen. Beteiligte Einrichtung: BIO5 Institute, University of Arizona, Tucson, AZ, U.S.A. Hauptthemen laut MEDLINE: Biphenyl Compounds, Blood-Brain Barrier, Disease Models, Animal, Tetrazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association (AHA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blockade of Angiotensin type 1 receptor (AT1R) has potential therapeutic utility in the treatment of numerous detrimental consequences of epileptogenesis, including oxidative stress, neuroinflammation, and blood–brain barrier (BBB) dysfunction. We have recently shown that many of these pathological processes play a critical role in seizure onset and propagation in the Scn8a-N1768D mouse model. Here we investigate the efficacy and potential mechanism(s) of action of candesartan (CND), an FDA-approved angiotensin receptor blocker (ARB) indicated for hypertension, in improving outcomes in this model of pediatric epilepsy. We compared length of lifespan, seizure frequency, and BBB permeability in juvenile (D/D) and adult (D/+) mice treated with CND at times after seizure onset. We performed RNAseq on hippocampal tissue to quantify differences in genome-wide patterns of transcript abundance and inferred beneficial and detrimental effects of canonical pathways identified by enrichment methods in untreated and treated mice. Our results demonstrate that treatment with CND gives rise to increased survival, longer periods of seizure freedom, and diminished BBB permeability. CND treatment also partially reversed or ‘normalized’ disease-induced genome-wide gene expression profiles associated with inhibition of NF-κB, TNFα, IL-6, and TGF-β signaling in juvenile and adult mice. Pathway analyses reveal that efficacy of CND is due to its known dual mechanism of action as both an AT1R antagonist and a PPARγ agonist. The robust effectiveness of CND across ages, sexes and mouse strains is a positive indication for its translation to humans and its suitability of use for clinical trials in children with SCN8A epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biphenyl CompoundsBlood-Brain BarrierDisease Models, AnimalTetrazolesBenzimidazolesAngiotensin II Type 1 Receptor BlockersAnimalsLongevityEpilepsyMaleMiceHippocampusGene Knock-In TechniquesMice, Inbred C57BLNAV1.6 Voltage-Gated Sodium ChannelFemaleSeizuresGene Expression Regulation

Stichwörter der Autor:innen

RNAseqScn8aangiotensin receptor blockerchronic seizuresepileptogenesisneurodevelopmental disorders

Substanzen

Biphenyl CompoundscandesartanTetrazolesBenzimidazolesAngiotensin II Type 1 Receptor BlockersNAV1.6 Voltage-Gated Sodium Channel

Autor:innen und Institutionen

  • BIO5 Institute, University of Arizona, Tucson, AZ, U.S.A.
  • Department of Neurology, University of Arizona, Tucson, AZ, U.S.A.
  • Department of Pharmacology, University of Arizona, Tucson, AZ, U.S.A.
  • Department of Mathematics, University of Arizona, Tucson, AZ, U.S.A.

ORCID-Profile: Michael F Hammer

Förderung

  • American Heart Association (AHA)

Zitieren

APA

Hammer, M. F., Bahramnejad, E., Watkins, J. C., & Ronaldson, P. T. (2024). Candesartan restores blood–brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis. Clinical Science. https://doi.org/10.1042/cs20240771

Vancouver

Hammer MF, Bahramnejad E, Watkins JC, Ronaldson PT. Candesartan restores blood–brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis. Clinical Science. 2024. doi:10.1042/cs20240771

BibTeX
@article{Hammer2024,
  author = {Hammer, Michael F and Bahramnejad, Erfan and Watkins, Joseph C and Ronaldson, Patrick T},
  title = {Candesartan restores blood–brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis},
  journal = {Clinical Science},
  year = {2024},
  doi = {10.1042/cs20240771}
}
Kostenlos starten →